Medical Oncologist
CION Cancer Clinics
MLH1 and the highest Lynch syndrome risks, in plain words | CION Cancer Clinics
Among the four Lynch syndrome genes, MLH1 and MSH2 carry the highest risks of bowel and womb cancer. MLH1 sits at the centre of the DNA repair system, and when it fails there is no backup. This page explains what that means, why it does not make cancer certain, and how it shapes when checks start and how often they repeat. At CION Cancer Clinics, our oncologists explain what a gene result means for you and your family, and plan the checks that follow.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Why do MLH1 carriers have the highest Lynch risks?
- How does MLH1 compare with the other Lynch genes?
- How does a specialist use the MLH1 result to plan your checks?
- The words you will meet, in plain language
- An MLH1 result and a PMS2 result, compared
- What people often assume about the highest-risk Lynch gene
- What this page cannot tell you
- Common questions about MLH1 and Lynch risk
The short answer
Why do MLH1 carriers have the highest Lynch risks?
Because MLH1 sits at the centre of the DNA repair team. When it fails, the whole mismatch repair system stops, with no backup to take over. Faults in some of the other Lynch genes leave part of the system working. That is why MLH1 carriers, along with MSH2 carriers, have the highest bowel and womb cancer risks among the four Lynch genes.
What highest actually means here
It is a comparison between Lynch genes. It does not mean every MLH1 carrier will develop cancer. Many never do. It means the risk is high enough, and can appear early enough, that checks need to start sooner and happen more often than for carriers of other Lynch genes.
Why the gene name matters to your plan
Guidelines used to treat all Lynch syndrome the same way. They now separate the genes, because the risks differ. Your report's gene name is one of the first things a specialist looks at when deciding how early to start colonoscopy and what else to check.
A higher risk is a reason for closer checks. It is not a prediction about you.The four Lynch genes
How does MLH1 compare with the other Lynch genes?
All four cause Lynch syndrome. They do not carry the same risk, and the difference shapes how each carrier is looked after.
MLH1
A core repair gene with no real backup. Carriers have among the highest bowel cancer risks in Lynch syndrome, often at younger ages, and a raised womb cancer risk in women.
MSH2
The other core gene. Bowel and womb risks are similar to MLH1, and risks outside the bowel, such as the urinary tract and skin, tend to be higher.
MSH6
A partner gene with some backup. Bowel risk is lower and tends to appear later. Womb cancer risk stays substantial, so women still need a clear plan.
PMS2
MLH1's partner, and the gene with the lowest risks of the four. Checks usually start later and may be less frequent.
Worth knowing
- Harder to test accurately
- Risks are still above average
Not sure whether this applies to you?
Ask an oncologistFrom gene to plan
How does a specialist use the MLH1 result to plan your checks?
Confirm the gene and the change
The counsellor checks that the report names a harmful MLH1 change, not an uncertain one. Only a confirmed fault starts a Lynch plan.
Look at the family history
The ages at which relatives were diagnosed matter. If someone had bowel cancer unusually young, checks may start even earlier than the gene alone suggests.
Set the bowel schedule
For MLH1, colonoscopy usually starts in early adult life and is repeated more often than for MSH6 or PMS2 carriers.
Add the other organs
Women discuss the womb and ovaries. Some carriers are offered stomach checks. The plan is reviewed as new evidence and family events come along.
On your report
The words you will meet, in plain language
- Lynch syndrome
- An inherited fault in MLH1, MSH2, MSH6 or PMS2. It raises the risk of bowel, womb and several other cancers.
- Mismatch repair
- The system that corrects copying errors in DNA. The four Lynch genes are its main parts.
- Penetrance
- How often a fault actually leads to cancer across everyone who carries it. It differs between the four Lynch genes.
- Lifetime risk
- The chance of developing a cancer over a whole life. It is an average across many carriers, not a forecast for one person.
- Age of onset
- How old people usually are when a cancer is found. It tends to be younger in MLH1 and MSH2 carriers.
- Gene-specific surveillance
- A check-up plan tailored to which Lynch gene you carry, rather than one plan for everyone.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Side by side
An MLH1 result and a PMS2 result, compared
MLH1 carrier
PMS2 carrier
Among the highest bowel risks in Lynch
The lowest risks of the four genes
Colonoscopy starts in early adult life
Colonoscopy usually starts later
Womb risk clearly raised
Womb risk raised, but less so
Cancers can appear at younger ages
Cancers tend to appear later, if at all
Commonly believed
What people often assume about the highest-risk Lynch gene
"Highest risk means I will get cancer."
It means your risk is higher than other Lynch carriers. Many MLH1 carriers never develop cancer, and regular colonoscopy removes polyps before most can turn into one.
"All Lynch syndrome is the same."
Not any more. The four genes carry different risks, and modern plans reflect that. A cousin with PMS2 may be told something quite different from you.
"The risk figures online apply to me."
Published figures vary widely by study. Older studies came from families with many cancers and ran higher. Most come from Europe and North America, and Indian data are still limited.
"Nothing can be done about a high-risk gene."
A great deal can. Frequent colonoscopy, options for the womb and ovaries, and discussing aspirin with your doctor all lower the chance of a late diagnosis.
Being straight with you
What this page cannot tell you
It cannot give you your own risk. A lifetime figure is an average across thousands of carriers, and your family history, sex and age all move you within it. The counsellor who ordered your test can explain what the figures mean for you.
It cannot settle the numbers
Researchers still disagree on exact risk levels for each gene and each organ. Figures from large carrier databases have been revised more than once. Studies in Indian families are small. That is why this page describes risk in plain words rather than precise figures.
Who this does not apply to
If you carry a fault in MSH6 or PMS2, your risks and your schedule are likely to be lower than described here. If your report shows a variant of uncertain significance in MLH1, it should not be treated as a positive result. And if MLH1 was missing only in a tumour, you may not carry an inherited fault at all.
What your specific variant means is a question for the counsellor who ordered the test.Questions we are asked
Common questions about MLH1 and Lynch risk
Is MLH1 worse than MSH2?
They are broadly similar for bowel and womb cancer, and together they carry the highest Lynch risks. MLH1 tends to be more bowel-focused. MSH2 carries more risk in other organs, such as the urinary tract. Your plan will reflect whichever gene you carry.
Why is my colonoscopy more frequent than my cousin's?
If your cousin carries a different Lynch gene, such as PMS2 or MSH6, their risk is lower and their checks may start later. Within one family carrying the same gene, schedules can still differ with age and past findings.
Do MLH1 carriers get cancer younger?
On average, cancers tend to appear at younger ages in MLH1 and MSH2 carriers than in MSH6 or PMS2 carriers. That is the main reason colonoscopy starts in early adult life. It does not mean cancer will appear at a young age in you.
Does a man with MLH1 face the same risk as a woman?
Bowel cancer risk is raised in both, and some studies suggest it is a little higher in men. Women also carry womb and ovary risks. Men still pass the fault to children exactly as often as women do.
Can lifestyle lower my risk?
Not smoking, keeping a healthy weight and staying active help, as they do for everyone. They do not remove the inherited risk. Regular colonoscopy remains the step that makes the biggest difference for MLH1 carriers.
Should I have preventive surgery because the risk is high?
For the womb and ovaries, it is one option once a woman has finished having children. For the bowel, regular colonoscopy is usually preferred to removing a healthy bowel. These are personal decisions made with your specialists over time.
Where do the risk figures come from?
Mostly from large databases that follow carriers in Europe, North America and Australia over many years. They are revised as more people are followed. Indian families are under-represented, so figures may not fit perfectly here.
What should I do first?
Make sure your report has been explained by a genetic counsellor, then book your first colonoscopy. Share the family letter with brothers, sisters and parents. Call the CION helpline if you need help arranging any of these steps.
Your Specialists
Meet CION's oncologists. Bring your family history or genetic report to them.
Our medical oncologists see people with a strong family history of cancer, arrange genetic counselling and testing where it fits, and plan the checks that follow.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- GeneReviews (NCBI) — Lynch Syndrome
- National Cancer Institute — Genetics of Colorectal Cancer (PDQ)
- MedlinePlus Genetics — MLH1 gene
- MedlinePlus Genetics — Lynch syndrome
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
MLH1 mutation: which cancers and what riskOrgan by organ, what an MLH1 fault affectsSurveillance for MLH1 carriersThe checks that follow from a higher riskThe MLH1 gene: what it doesHow the repair system works, in plain wordsWhy colonoscopy is so frequent in LynchThe reason polyps are checked so often
Talk to us
Want to understand what your MLH1 result means for your checks?
Bring your report and your family history. We will help you understand the plan your specialists suggest and arrange the first steps. One helpline serves every CION centre.